| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.184 | - | 14.746 | 19.604 | 36.963 | 47.411 | 50.018 | 59.250 | 65.181 |
| Total Income - EUR | - | 6.184 | - | 15.050 | 19.604 | 36.963 | 47.580 | 50.042 | 59.264 | 65.303 |
| Total Expenses - EUR | - | 1.887 | - | 10.012 | 13.763 | 22.121 | 34.307 | 45.349 | 54.367 | 63.852 |
| Gross Profit/Loss - EUR | - | 4.297 | - | 5.038 | 5.842 | 14.841 | 13.273 | 4.693 | 4.897 | 1.451 |
| Net Profit/Loss - EUR | - | 4.157 | - | 4.887 | 5.647 | 14.500 | 12.854 | 4.192 | 4.304 | 619 |
| Employees | - | 1 | - | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
Check the financial reports for the company - Bba Better Injectors S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 2.738 | - | 1.905 | 1.507 | 1.123 | 19.937 | 17.194 | 34.890 | 6.975 |
| Current Assets | - | 2.711 | - | 11.348 | 17.272 | 32.738 | 27.623 | 32.926 | 21.860 | 54.101 |
| Inventories | - | 0 | - | 0 | 0 | 0 | 0 | 15.204 | 7.819 | 49.031 |
| Receivables | - | 401 | - | 0 | 211 | 0 | 849 | 0 | 0 | 80 |
| Cash | - | 2.311 | - | 11.348 | 17.061 | 32.738 | 26.774 | 17.722 | 14.040 | 4.989 |
| Shareholders Funds | - | 4.201 | - | 12.373 | 17.780 | 31.944 | 44.090 | 48.419 | 52.576 | 52.902 |
| Social Capital | - | 45 | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.248 | - | 880 | 998 | 1.917 | 3.471 | 1.702 | 4.173 | 8.174 |
| Income in Advance | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9531 - 9531" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Bba Better Injectors S.r.l.